GETI B logo

Getinge AB (publ) Stock Price

OM:GETI B Community·SEK 52.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

GETI B Share Price Performance

SEK 191.20
9.45 (5.20%)
SEK 270.00
Fair Value
SEK 191.20
9.45 (5.20%)
29.2% undervalued intrinsic discount
SEK 270.00
Fair Value
Price SEK 191.20
AnalystHighTarget SEK 270.00
AnalystConsensusTarget SEK 229.44
AnalystLowTarget SEK 170.97

GETI B Community Narratives

AnalystHighTarget·
Fair Value SEK 270 29.2% undervalued intrinsic discount

Aging Populations, Digital Health And Emerging Markets Will Spur Lifesaving Demand

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·
Fair Value SEK 229.44 16.7% undervalued intrinsic discount

Advanced Digital Health And Infection Control Will Drive Future Markets

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystLowTarget·
Fair Value SEK 170.97 11.8% overvalued intrinsic discount

Rising Tariffs And Regulation Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SEK 270
29.2% undervalued intrinsic discount
Revenue
6.58% p.a.
Profit Margin
9.57%
Future PE
21.81x
Price in 2029
SEK 324.39
SEK 170.97
11.8% overvalued intrinsic discount
Revenue
3.28% p.a.
Profit Margin
8.61%
Future PE
16.86x
Price in 2029
SEK 205.27
SEK 229.44
16.7% undervalued intrinsic discount
Revenue
4.12% p.a.
Profit Margin
9.42%
Future PE
20.06x
Price in 2029
SEK 273.86

Trending Discussion

Updated Narratives

GETI B logo

GETI B: Dividend Proposal Will Support Confidence Despite Lower Margin Assumptions

Fair Value: SEK 270 29.2% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GETI B logo

GETI B: Slightly Higher Dividend Will Still Leave P/E Looking Stretched

Fair Value: SEK 170.97 11.8% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GETI B logo

GETI B: Higher Dividend Proposal Will Underpin Future Shareholder Returns

Fair Value: SEK 229.44 16.7% undervalued intrinsic discount
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

1 Risk
4 Rewards

Getinge AB (publ) Key Details

SEK 35.0b

Revenue

SEK 18.3b

Cost of Revenue

SEK 16.7b

Gross Profit

SEK 14.4b

Other Expenses

SEK 2.3b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 21, 2026
8.29
47.63%
6.46%
31.9%
View Full Analysis

About GETI B

Founded
1904
Employees
11670
CEO
Mattias Perjos
WebsiteView website
www.getinge.com

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Recent GETI B News & Updates

Getinge AB (publ) Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Mar 29
Getinge AB (publ) Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Recent updates

No updates